Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
Yacyshyn, B R, Chey, W Y, Goff, J, Salzberg, B, Baerg, R, Buchman, A L, Tami, J, Yu, R, Gibiansky, E, Shanahan, W R
Published in Gut (01.07.2002)
Published in Gut (01.07.2002)
Get full text
Journal Article
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
Yacyshyn, B R, Bowen-Yacyshyn, M B, Jewell, L, Tami, J A, Bennett, C F, Kisner, D L, Shanahan, Jr, W R
Published in Gastroenterology (New York, N.Y. 1943) (01.06.1998)
Published in Gastroenterology (New York, N.Y. 1943) (01.06.1998)
Get more information
Journal Article
Antiretroviral Activity of the Anti-CD4 Monoclonal Antibody TNX-355 in Patients Infected with HIV Type 1
Kuritzkes, Daniel R., Jacobson, Jeffrey, Powderly, William G., Godofsky, Eliot, DeJesus, Edwin, Haas, Frances, Reimann, Keith A., Larson, Jeffrey L., Yarbough, Patrice O., Curt, Valentin, Shanahan, William R.
Published in The Journal of infectious diseases (15.01.2004)
Published in The Journal of infectious diseases (15.01.2004)
Get full text
Journal Article
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
Glover, J M, Leeds, J M, Mant, T G, Amin, D, Kisner, D L, Zuckerman, J E, Geary, R S, Levin, A A, Shanahan, Jr, W R
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Journal Article
Responsive in-season nitrogen management for cereals
Shanahan, J.F., Kitchen, N.R., Raun, W.R., Schepers, J.S.
Published in Computers and electronics in agriculture (01.04.2008)
Published in Computers and electronics in agriculture (01.04.2008)
Get full text
Journal Article
Conference Proceeding
Preclinical and clinical pharmacology of antisense oligonucleotides
MARCUSSON, E. G, YACYSHYN, B. R, SHANAHAN, W. R, DEAN, N. M
Published in Molecular biotechnology (01.08.1999)
Published in Molecular biotechnology (01.08.1999)
Get full text
Journal Article
Effect of Anti-IgE Therapy in Patients with Peanut Allergy
Leung, Donald Y.M, Sampson, Hugh A, Yunginger, John W, Burks, A. Wesley, Schneider, Lynda C, Wortel, Cornelis H, Davis, Frances M, Hyun, John D, Shanahan, William R
Published in The New England journal of medicine (13.03.2003)
Published in The New England journal of medicine (13.03.2003)
Get full text
Journal Article
Assessment of longterm benefit of total hip replacement in patients with ankylosing spondylitis
Shanahan, Jr, W R, Kaprove, R E, Major, P A, Hunter, T, Baragar, F D
Published in Journal of rheumatology (01.01.1982)
Get more information
Published in Journal of rheumatology (01.01.1982)
Journal Article
Clinical Operations Variables are Associated With Blood Pressure Outcomes
Kressin, Nancy R, Lasser, Karen E, Paasche-Orlow, Michael, Allison, Jeroan, Ash, Arlene S, Adams, William G, Shanahan, Christopher W, Legler, Aaron, Pizer, Steven D
Published in Medical care (01.06.2015)
Published in Medical care (01.06.2015)
Get more information
Journal Article
Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection
Kahan, Barry D, Stepkowski, Stanislaw, Kilic, Murat, Katz, Steven M, Van Buren, Charles T, Welsh, Maria S, Tami, Joseph A, Shanahan, Jr, William R
Published in Transplantation (27.09.2004)
Published in Transplantation (27.09.2004)
Get more information
Journal Article
Assessing information synthesis within and across multiple texts with verification tasks: a signal detection theory approach
Yukhymenko-Lescroart, Mariya A., Goldman, Susan R., Lawless, Kimberly A., Pellegrino, James W., Shanahan, Cynthia R.
Published in Educational psychology (Dorchester-on-Thames) (28.05.2022)
Published in Educational psychology (Dorchester-on-Thames) (28.05.2022)
Get full text
Journal Article
SAT0240 Phase 3 trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE)
Merrill, J, Martin, RS, Shanahan, WR, Scheinberg, M, Kalunian, K, Wofsy, D
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article